Physician profile

Frances Kipfer

Davie, FL

NPI 1902368277

$628.11

in general payments reported to CMS, 2019-2025

10 companies · $42.74 in 2025

The $42.74 reported for 2025 was less than what a typical provider received nationally.

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$153.53

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $284.88 2022-2025
Astrazeneca Pharmaceuticals LP $120.65 2021
Boehringer Ingelheim Pharmaceuticals, INC. $47.69 2022-2023
Bayer Healthcare Pharmaceuticals INC. $37.41 2022
Novo Nordisk INC $35.51 2022
Takeda Pharmaceuticals U.S.A., INC. $26.33 2022
Si-Bone, INC. $23.86 2023
Exact Sciences Corporation $19.70 2025 Cologuard Collection Kit
Antares Pharma, INC. $19.12 2022
Vistapharm, INC. $12.96 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Frances Kipfer

$628.11

in general payments reported 2019-2025

Years
2021-2025
Top company
Abbvie INC.
Context
The $42.74 reported for 2025 was less than what a typical provider received nationally.

https://glasscript.com/doctor/11292056/frances-kipfer

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.